IBM Q2 Earnings Miss Estimates as Software Growth Offsets Infrastructure Weakness 
US-Mexico USMCA Talks Advance as Auto Rules Remain Major Sticking Point 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Cathay Pacific Sees H1 Profit Surge on Strong Travel Demand 
European Stocks Flat as Oil Tops $100, Trump Tariffs Fuel Inflation Fears 
Japan Yen Slides Past 163 as Middle East Tensions Lift US Dollar, Oil Prices 
Gold Price Surges Above $4,100 as Middle East Tensions Boost Safe-Haven Demand 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Australia ASIC Tightens Auditor Oversight After KPMG Leak Scandal 
Brent Oil Holds Above $100 as Red Sea Attacks, Iran Conflict Threaten Global Supply 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Oracle Stock Rises After Winning Up to $6.99 Billion U.S. Defense Software Contract 
Trump Administration Imposes New Forced Labor Tariffs on 60 Trading Partners 
Pakistan Seeks $10 Billion U.S. Exchange Stabilization Fund to Boost Forex Reserves 
China vs. NASA: The New Moon Race and What's at Stake by 2030 
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix 
Wistron Opens $700M Texas AI Factory to Build Nvidia Superchips in U.S. 
Naver Cloud became the first South Korean cloud service provider to develop a gene data analysis platform.
The newly-developed Nvidia Clara Parabricks on the platform of Naver Cloud, an affiliate of South Korea’s leading internet portal operator Naver Corp., is the combination of the Naver Cloud server with US graphics chip giant Nvidia Corp.’s Clara Parabricks software suite.
Clara Parabricks is a system that uses huge graphic processing units to interpret gene data.
Naver Cloud plans to launch the Genome Analysis All-in-One Integrated Platform in its marketplace in the first half of this year, in conjunction with local personal genomics business ichrogene.
Beginning with the cooperation with Nvidia and ichrogene, Naver Cloud will continue to expand its presence in the gene analysis market, according to the company’s executive director, Han Sang-young.
